← Back to Insights
Hospice Non Grata
Aether Industry Intelligence
The Weekly Download | Reporting period: November 7–13
CMS extends the enrollment freeze but reopens a path for existing operators
- CMS has extended the nationwide Medicare enrollment moratorium for hospices and home health agencies by another six months, effective November 13, 2026. The decision, announced November 12, confirms that the federal fraud crackdown is becoming a sustained industry intervention rather than a temporary disruption.
- The extension continues to prohibit initial Medicare enrollment applications and certain changes in majority ownership. However, CMS has made one important concession: existing Medicare-enrolled providers can now add new practice locations within their existing enrollment in the same state, an activity restricted under the original moratorium.
- This changes the competitive landscape. Established operators now have a permitted expansion pathway that new entrants do not, potentially favoring incumbents with capital, referral relationships, and operating infrastructure. It could also increase the attractiveness of existing Medicare-enrolled hospice businesses.
- CMS said its October two-day enforcement operation in California resulted in 145 provider revocations associated with more than $703 million in Medicare and Medicaid payments. These figures cover both hospice and home health providers, and the payment figure should not be interpreted as a confirmed fraud-loss total.
- The agency is also strengthening enrollment controls through retroactive revocation provisions and additional scrutiny of ownership, provider clustering, and medical directors or administrators responsible for multiple hospices. This increases the potential consequences of weak governance, particularly for multi-location operators.
- For smaller independent hospices, the revised moratorium presents both an opportunity and a challenge. Existing providers may have more room to expand, but larger competitors may be better positioned to finance new locations, recruit clinical staff, and establish referral relationships.
- As an industry we can’t assume that greater enforcement automatically translates into better patient care. Removing fraudulent operators is beneficial, but restricting new entry can also reduce competition or delay access in underserved markets. Whether the moratorium improves outcomes depends on enforcement accuracy and how remaining providers respond.
- The most important question is whether sustained oversight will encourage hospices to invest in better clinical documentation and internal controls or simply increase administrative burden without meaningful changes. The better test is whether operators can identify a recurring, expensive workflow that can be measurably improved.
- The big picture: The extended moratorium potentially strengthens established hospice operators, while increasing the importance of strong governance and operations. The question is whether providers can meet a higher bar for oversight while maintaining sustainable economics and reducing administrative burden.
Primary sources: CMS announcement, November 12 · CMS enrollment moratoria guidance